Status:
UNKNOWN
Factors Associated With Survival in Patients Having Pneumocystis Jirovecii
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Pneumocystis Jirovecii Infection
Eligibility:
All Genders
18+ years
Brief Summary
Pneumocystis jirovecii is a fungus that can colonize the airways of some patients and be responsible for a disease called pneumocystosis in other patients and mainly in immunocompromised patients. Pn...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult patients with a positive respiratory sample for P. jirovecii cared for in Strasbourg University Hospitals between 01/01/2016 and 31/12/2018. Positive samples are defined as a direct examination finding cysts or trophozoites after staining with May-Grunewald-Giemsa and/or Gomori-Grocott, a positive P. jirovecii PCR on sputum, tracheal aspirates or bronchial fluid -alveolar
- Subject not objecting to the reuse of their data for scientific research purposes.
- Exclusion criteria:
- \- Subject having expressed its opposition to the reuse of its data for scientific research purposes.
Exclusion
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 10 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06173453
Start Date
January 1 2023
End Date
October 10 2025
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Strasbourg, France, 67091